MOTT DAVID M
Insider CIK 1219871 · NVAX Director · ILIU 10% owner · CVT 10% owner · PHAS 10% owner · GLYC 10% owner · AKAO 10% owner · AVEO 10% owner · WDAY 10% owner · MM 10% owner · HIVE 10% owner · BOX 10% owner · MULE 10% owner · TCON 10% owner · CASC 10% owner · CRCM 10% owner · ARDX Director, 10% owner · APPN 10% owner · MRSN Director, 10% owner · GNCA 10% owner · CLVS 10% owner · ROKA 10% owner · NET 10% owner · OMTH Director, 10% owner · RARX 10% owner · TSRO Director, 10% owner · RGLS 10% owner · SPT 10% owner · MIRN 10% owner · CERC 10% owner · DERM 10% owner · GRTX 10% owner · TRVI 10% owner · EPZM Director, 10% owner · LOXO 10% owner · ADAP Director, 10% owner · RYTM 10% owner · IMRA Director · ESTC 10% owner · NITE Director, 10% owner · SURF 10% owner · OYST 10% owner · MIRM 10% owner · ABIO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVAX NOVAVAX INC | M Exercise deriv | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 79,770 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,180 | — | $0 | 14,180 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 21,270 | — | $0 | 21,270 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2026-06-16 | 2026-06-18 | 20,282 | — | $0 | 3,323,200 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 3,349,655 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2026-02-20 | 2026-02-23 | 333,333 | $5.84 | $1.95M | 3,302,918 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 264 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,460 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 400 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,011 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 788 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 368 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,200 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 734 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,800 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 740 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,002 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 181 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 23,546 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 383 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 28,326 | $6.42 | $181.9K | 28,326 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 18,884 | — | $0 | 18,884 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 2,969,585 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2025-06-18 | 2025-06-23 | 31,163 | — | $0 | 2,928,034 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2025-06-16 | 2025-06-18 | 200,000 | $3.63 | $726.0K | 2,896,871 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 61,500 | — | $0 | 61,500 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2025-06-12 | 2025-06-13 | 10,420 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2025-06-12 | 2025-06-13 | 10,420 | — | $0 | 60,890 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2025-06-09 | 2025-06-11 | 200,000 | $3.69 | $738.0K | 2,696,871 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2025-05-15 | 2025-05-19 | 100,000 | $3.29 | $329.0K | 2,496,871 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2025-05-02 | 2025-05-05 | 381,377 | $4.22 | $1.61M | 2,396,871 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2025-02-24 | 2025-02-26 | 77,729 | $5.00 | $388.6K | 2,015,494 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2025-01-21 | 2025-01-22 | 199,000 | $4.99 | $993.0K | 1,937,765 | SEC↗ |
| ARDX ARDELYX, INC. | M Exercise deriv | 2024-12-26 | 2024-12-27 | 100,000 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | M Exercise | 2024-12-26 | 2024-12-27 | 100,000 | $0.55 | $55.0K | 1,738,765 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2024-12-19 | 2024-12-23 | 213,300 | $4.67 | $996.1K | 1,638,765 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2024-11-13 | 2024-11-14 | 215,868 | $4.62 | $997.3K | 1,425,465 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-07-01 | 2024-07-01 | 1,583,214 | — | $0 | 1,583,214 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2024-06-14 | 2024-06-17 | 17,322 | — | $0 | 1,209,597 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 10,420 | — | $0 | 10,420 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 15,630 | $15.86 | $247.9K | 15,630 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 50,470 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2024-01-02 | 2024-01-04 | 8,810 | — | $0 | 588,694 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2023-10-02 | 2023-10-04 | 15,873 | — | $0 | 579,884 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-03 | 2023-07-03 | 1,462,927 | — | $0 | 1,462,927 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2023-07-03 | 2023-07-06 | 6,079 | — | $0 | 564,011 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2023-06-15 | 2023-06-16 | 49,237 | — | $0 | 49,237 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2023-06-15 | 2023-06-16 | 25,510 | — | $0 | 1,192,275 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 6,670 | — | $0 | 6,670 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 7,710 | — | $0 | 7,710 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2023-06-10 | 2023-06-13 | 3,100 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2023-06-10 | 2023-06-13 | 3,100 | — | $0 | 43,800 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 18,355 | — | $0 | 18,355 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2023-06-08 | 2023-06-12 | 14,467 | — | $0 | 557,932 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2023-04-03 | 2023-04-05 | 4,866 | — | $0 | 543,465 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2022-11-17 | 2022-11-17 | 567,000 | $1.76 | $997.9K | 1,166,765 | SEC↗ |
| EPZM Epizyme, Inc. | U Tender | 2022-08-12 | 2022-08-16 | 106,959 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | U Tender | 2022-08-12 | 2022-08-16 | 215,494 | — | $0 | 8,994 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 8,994 | — | $0 | 0 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-07-01 | 2022-07-01 | 1,000,439 | — | $0 | 1,000,439 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-06-30 | 2022-07-05 | 16,156 | $1.47 | $23.7K | 224,488 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2022-06-17 | 2022-06-21 | 700 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2022-06-17 | 2022-06-21 | 700 | — | $0 | 40,700 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2022-06-15 | 2022-06-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2022-06-15 | 2022-06-21 | 182,481 | — | $0 | 599,765 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-06-10 | 2022-06-14 | 4,600 | — | $0 | 4,600 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-06-10 | 2022-06-14 | 3,100 | — | $0 | 3,100 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 8,500 | — | $0 | 8,500 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 41,006 | — | $0 | 41,006 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-05-17 | 2022-05-19 | 8,994 | — | $0 | 208,332 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-03-31 | 2022-04-01 | 20,653 | $1.15 | $23.8K | 199,338 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-23 | 2022-02-23 | 35,257 | $1.46 | $51.5K | 229,224 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-22 | 2022-02-23 | 65,817 | $1.56 | $102.7K | 193,967 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-18 | 2022-02-23 | 50,398 | $1.30 | $65.5K | 128,150 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-17 | 2022-02-17 | 14,595 | $1.17 | $17.1K | 77,752 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-16 | 2022-02-17 | 11,779 | $1.20 | $14.1K | 63,157 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-15 | 2022-02-17 | 19,552 | $1.20 | $23.5K | 51,378 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-14 | 2022-02-14 | 8,500 | $1.18 | $10.0K | 31,826 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-11 | 2022-02-14 | 14,573 | $1.23 | $17.9K | 23,326 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2022-02-10 | 2022-02-14 | 8,753 | $1.29 | $11.3K | 8,753 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 18,518 | — | $0 | 18,518 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-12-31 | 2022-01-04 | 9,500 | $2.50 | $23.8K | 178,685 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-09-30 | 2021-10-01 | 4,640 | $5.12 | $23.8K | 169,185 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-23 | 2021-09-24 | 5,728 | $251.32 | $1.44M | 59,233 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-23 | 2021-09-24 | 7,557 | $252.56 | $1.91M | 51,676 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-23 | 2021-09-24 | 1,200 | $255.38 | $306.5K | 40,000 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-23 | 2021-09-24 | 7,744 | $253.46 | $1.96M | 43,932 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-23 | 2021-09-24 | 2,732 | $254.46 | $695.2K | 41,200 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-07-01 | 2021-07-02 | 579,494 | — | $0 | 579,494 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-06-30 | 2021-07-01 | 2,858 | $8.31 | $23.7K | 164,545 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2021-06-29 | 2021-06-30 | 7,728 | — | $0 | 7,728 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-06-17 | 2021-06-22 | 1,300 | — | $0 | 1,300 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-06-17 | 2021-06-22 | 700 | — | $0 | 700 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2021-06-16 | 2021-06-21 | 32,765 | — | $0 | 32,765 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 40,559 | — | $0 | 40,559 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 25,050 | — | $0 | 25,050 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-06-11 | 2021-06-15 | 8,060 | — | $0 | 161,687 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-03-31 | 2021-04-01 | 2,727 | $8.71 | $23.8K | 153,627 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2021-03-26 | 2021-03-29 | 217 | $7.80 | $1.7K | 150,900 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2021-03-26 | 2021-03-29 | 34,269 | $7.97 | $273.1K | 150,683 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2021-03-25 | 2021-03-29 | 28,231 | $7.98 | $225.3K | 116,414 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 4,528 | — | $0 | 4,528 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-12-31 | 2021-01-05 | 2,158 | $10.86 | $23.4K | 88,183 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-12-14 | 2020-12-15 | 486 | — | $0 | 9,595 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-12-14 | 2020-12-15 | 1,096 | — | $0 | 9,109 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2020-12-10 | 2020-12-10 | 170,000 | $5.89 | $1.00M | 417,284 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-12-01 | 2020-12-03 | 1,117 | — | $0 | 7,517 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-12-01 | 2020-12-03 | 496 | — | $0 | 8,013 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-11-09 | 2020-11-12 | 1,112 | — | $0 | 6,400 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-11-09 | 2020-11-12 | 496 | — | $0 | 5,288 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-09-30 | 2020-10-01 | 1,965 | $11.93 | $23.4K | 86,025 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-09-22 | 2020-09-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-09-14 | 2020-11-12 | 496 | — | $0 | 4,792 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-09-14 | 2020-11-12 | 1,106 | — | $0 | 4,296 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-07-01 | 2020-07-01 | 226,753 | — | $0 | 226,753 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-06-30 | 2020-07-01 | 1,459 | $16.06 | $23.4K | 84,060 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2020-06-26 | 2020-06-26 | 62,019 | $16.03 | $994.2K | 82,601 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-06-25 | 2020-06-26 | 4,400 | — | $0 | 4,400 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-06-25 | 2020-06-29 | 9,200 | — | $0 | 9,200 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2020-06-25 | 2020-06-26 | 68,373 | $6.96 | $475.9K | 247,284 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2020-06-24 | 2020-06-26 | 72,598 | $6.75 | $490.0K | 178,911 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2020-06-22 | 2020-06-24 | 4,673 | $6.75 | $31.5K | 106,313 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2020-06-18 | 2020-06-22 | 67,662 | — | $0 | 106,959 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-06-16 | 2020-06-18 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ARDX ARDELYX, INC. | J Other | 2020-06-10 | 2020-06-11 | 1,079 | — | $0 | 101,640 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2020-06-09 | 2020-06-11 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2020-06-09 | 2020-06-11 | 23,500 | — | $0 | 23,500 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2020-06-09 | 2020-06-11 | 12,995 | — | $0 | 100,561 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 14,013 | — | $0 | 14,013 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-04-09 | 2020-04-13 | 2,197 | — | $0 | 2,197 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-04-09 | 2020-04-13 | 993 | — | $0 | 3,190 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2020-04-07 | 2020-04-09 | 538,599 | $5.59 | $3.01M | 538,599 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-03-31 | 2020-04-02 | 1,512 | $15.51 | $23.5K | 20,582 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2020-03-16 | 2020-03-16 | 15,457 | — | $0 | 15,457 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2020-01-24 | 2020-01-28 | 7,500,000 | $0.67 | $5.03M | 19,500,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 19,713 | — | $0 | 19,713 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-12-31 | 2020-01-03 | 952 | $24.60 | $23.4K | 19,070 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 900,900 | $6.66 | $6.00M | 900,900 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 9,009,000 | $0.13 | $1.17M | 9,009,000 | SEC↗ |
| SPT Sprout Social, Inc. | C Conversion deriv | 2019-12-17 | 2019-12-18 | 6,086,620 | — | $0 | 0 | SEC↗ |
| SPT Sprout Social, Inc. | C Conversion deriv | 2019-12-17 | 2019-12-18 | 1,837,275 | — | $0 | 0 | SEC↗ |
| SPT Sprout Social, Inc. | C Conversion deriv | 2019-12-17 | 2019-12-18 | 832,126 | — | $0 | 0 | SEC↗ |
| SPT Sprout Social, Inc. | C Conversion deriv | 2019-12-17 | 2019-12-18 | 268,679 | — | $0 | 0 | SEC↗ |
| SPT Sprout Social, Inc. | C Conversion | 2019-12-17 | 2019-12-18 | 1,837,275 | — | $0 | 7,923,895 | SEC↗ |
| SPT Sprout Social, Inc. | C Conversion | 2019-12-17 | 2019-12-18 | 268,679 | — | $0 | 9,024,700 | SEC↗ |
| SPT Sprout Social, Inc. | C Conversion | 2019-12-17 | 2019-12-18 | 832,126 | — | $0 | 8,756,021 | SEC↗ |
| SPT Sprout Social, Inc. | C Conversion | 2019-12-17 | 2019-12-18 | 6,086,620 | — | $0 | 6,086,620 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2019-12-09 | 2019-12-09 | 400,000 | $6.25 | $2.50M | 3,482,186 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 9,600,000 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 1,354,829 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 8,975,000 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 267,935 | — | $0 | 3,941,381 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 1,774,922 | — | $0 | 1,774,922 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 1,898,524 | — | $0 | 3,673,446 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-12 | 416,666 | $12.00 | $5.00M | 4,358,047 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 3,606,282 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 1,061,547 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 1,061,547 | — | $0 | 4,990,287 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | P Buy | 2019-11-04 | 2019-11-04 | 935,000 | $16.00 | $14.96M | 5,925,287 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 3,606,282 | — | $0 | 3,928,740 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-09-30 | 2019-10-02 | 2,271 | $10.32 | $23.4K | 18,118 | SEC↗ |
| NET Cloudflare, Inc. | C Conversion deriv | 2019-09-17 | 2019-09-18 | 42,463,920 | — | $0 | 48,588,474 | SEC↗ |
| NET Cloudflare, Inc. | C Conversion deriv | 2019-09-17 | 2019-09-18 | 4,059,376 | — | $0 | 0 | SEC↗ |
| NET Cloudflare, Inc. | C Conversion deriv | 2019-09-17 | 2019-09-18 | 7,183,310 | — | $0 | 0 | SEC↗ |
| NET Cloudflare, Inc. | C Conversion deriv | 2019-09-17 | 2019-09-18 | 35,280,610 | — | $0 | 0 | SEC↗ |
| NET Cloudflare, Inc. | C Conversion | 2019-09-17 | 2019-09-18 | 4,059,376 | — | $0 | 4,059,376 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 29,889,945 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 450,000 | $15.00 | $6.75M | 4,186,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 3,736,243 | — | $0 | 3,736,243 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-07-02 | 2019-07-03 | 350,947 | — | $0 | 350,947 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-06-30 | 2019-07-02 | 1,868 | $12.55 | $23.4K | 15,847 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2019-06-27 | 2019-06-28 | 52,473 | $12.43 | $652.2K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2019-06-26 | 2019-06-26 | 52,472 | $12.85 | $674.3K | 52,473 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2019-06-25 | 2019-06-26 | 52,472 | $13.31 | $698.4K | 104,945 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2019-06-24 | 2019-09-11 | 165,919 | — | $0 | 8,502 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2019-06-24 | 2019-06-26 | 38,646 | — | $0 | 39,297 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2019-06-24 | 2019-06-26 | 157,417 | — | $0 | 157,417 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2019-06-24 | 2019-06-26 | 767,500 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2019-06-24 | 2019-06-26 | 767,500 | — | $0 | 767,500 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2019-06-24 | 2019-06-26 | 2,500,000 | — | $0 | 3,971,018 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2019-06-13 | 2019-06-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2019-06-13 | 2019-06-17 | 32,846 | — | $0 | 87,566 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer deriv | 2019-06-07 | 2019-06-07 | 36,400 | $13.23 | $481.6K | 0 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer deriv | 2019-06-07 | 2019-06-07 | 21,000 | $11.93 | $250.5K | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer | 2019-06-07 | 2019-06-07 | 6,662,532 | $25.50 | $169.89M | 0 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-05-31 | 2019-06-07 | 17,633 | — | $0 | 17,633 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 17,099,315 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,500,000 | $10.00 | $15.00M | 4,438,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 1,938,562 | — | $0 | 1,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,000,000 | $10.00 | $10.00M | 2,938,562 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 3,703,704 | $0.13 | $481.5K | 3,703,704 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 256,700 | $10.80 | $2.77M | 256,700 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2019-05-07 | 2019-05-09 | 1,136,704 | $1.08 | $1.23M | 2,052,454 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy deriv | 2019-04-08 | 2019-04-08 | 4,347,827 | $0.01 | $43.5K | 4,347,827 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2019-04-08 | 2019-04-08 | 4,347,827 | $1.14 | $4.96M | 25,243,865 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-03-31 | 2019-06-07 | 1,891 | $12.39 | $23.4K | 13,979 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2019-03-05 | 2019-03-06 | 3,750,000 | $4.00 | $15.00M | 11,890,138 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| NITE Nightstar Therapeutics plc | A Award deriv | 2019-01-25 | 2019-01-29 | 21,000 | — | $0 | 21,000 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 12,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 7,290 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 12,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 4,052 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-22 | 739,517 | $75.00 | $55.46M | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-22 | 15,362 | $75.00 | $1.15M | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-22 | 1,333 | $75.00 | $100.0K | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-22 | 9,681,038 | $75.00 | $726.08M | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-01-02 | 2019-01-04 | 25,292 | — | $0 | 25,292 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-21 | 2018-12-21 | 300,000 | $1.49 | $447.0K | 20,896,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-20 | 2018-12-21 | 200,000 | $1.63 | $326.0K | 20,596,038 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2018-12-14 | 2018-12-14 | 645,161 | $15.50 | $10.00M | 6,135,234 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-11 | 2018-12-12 | 61,200 | $1.98 | $121.2K | 20,396,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-10 | 2018-12-10 | 26,000 | $1.98 | $51.5K | 20,334,838 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-07 | 2018-12-10 | 117,100 | $1.98 | $231.9K | 20,308,838 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-06 | 2018-12-10 | 27,300 | $1.99 | $54.3K | 20,191,738 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-30 | 2018-11-30 | 71,900 | $1.98 | $142.4K | 20,164,438 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-28 | 2018-11-30 | 24,500 | $1.99 | $48.8K | 20,092,538 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-20 | 2018-11-21 | 170,000 | $1.98 | $336.6K | 20,068,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-19 | 2018-11-19 | 510,000 | $1.88 | $958.8K | 19,898,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-16 | 2018-11-19 | 350,000 | $1.86 | $651.0K | 19,388,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-15 | 2018-11-19 | 340,000 | $1.86 | $632.4K | 19,038,038 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 1,177 | $5.00 | $5.9K | 3,279,627 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 3,279,627 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 181,190 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 181,190 | $0.12 | $21.7K | 442,055 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 4,349 | $5.00 | $21.7K | 437,706 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 437,706 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 49,030 | $0.12 | $5.9K | 3,280,804 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 49,030 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 1,124,301 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 1,800,000 | $5.00 | $9.00M | 6,641,634 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 4,841,634 | — | $0 | 4,841,634 | SEC↗ |
| ESTC Elastic N.V. | C Conversion deriv | 2018-10-10 | 2018-10-10 | 4,155,995 | — | $0 | 0 | SEC↗ |
| ESTC Elastic N.V. | C Conversion deriv | 2018-10-10 | 2018-10-10 | 1,528,117 | — | $0 | 0 | SEC↗ |
| ESTC Elastic N.V. | C Conversion | 2018-10-10 | 2018-10-10 | 4,155,995 | — | $0 | 4,155,995 | SEC↗ |
| ESTC Elastic N.V. | C Conversion | 2018-10-10 | 2018-10-10 | 1,528,117 | — | $0 | 1,528,117 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2018-10-05 | 2018-10-05 | 416,667 | $9.00 | $3.75M | 6,471,018 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-09-20 | 2018-09-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-09-07 | 2018-09-10 | 12,000,000 | $1.67 | $20.04M | 12,000,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-09-07 | 2018-09-10 | 3,000,000 | $1.67 | $5.01M | 82,978,668 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-08-21 | 2018-08-22 | 663,716 | $2.26 | $1.50M | 18,698,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-07-19 | 2018-07-20 | 50,600 | $2.00 | $101.2K | 18,034,322 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-07-18 | 2018-07-20 | 200,000 | $1.95 | $390.0K | 17,983,722 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2018-07-02 | 2018-07-02 | 6,088 | $13.55 | $82.5K | 12,088 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-06-28 | 2018-06-28 | 187,130 | $2.10 | $393.0K | 17,783,722 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-06-27 | 2018-06-28 | 5,295 | $2.15 | $11.4K | 17,596,592 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-06-22 | 2018-06-26 | 187,330 | — | $0 | 187,330 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2018-06-13 | 2018-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-06-13 | 2018-06-15 | 20,843 | — | $0 | 54,720 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 7,209 | — | $0 | 7,209 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 4,052 | — | $0 | 4,052 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2018-06-01 | 2018-06-05 | 2,537 | — | $0 | 15,362 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-30 | 2018-05-30 | 275 | $2.15 | $591 | 17,591,297 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-05-25 | 2018-05-30 | 416,666 | $4.00 | $1.67M | 3,082,186 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-05-25 | 2018-05-30 | 416,667 | $4.00 | $1.67M | 3,082,186 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-21 | 2018-05-21 | 32,200 | $2.14 | $68.9K | 17,591,022 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-05-18 | 2018-05-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-18 | 2018-05-21 | 20,100 | $2.14 | $43.0K | 17,558,822 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-17 | 2018-05-21 | 184,179 | $2.13 | $392.3K | 17,538,722 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-08 | 2018-05-10 | 70,873 | $2.13 | $151.0K | 17,354,543 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2018-05-01 | 2018-05-09 | 858,978 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2018-05-01 | 2018-05-09 | 2,576,939 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2018-05-01 | 2018-05-09 | 858,978 | — | $0 | 858,978 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | U Tender | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2018-05-01 | 2018-05-09 | 2,576,939 | — | $0 | 2,576,939 | SEC↗ |
| MULE MULESOFT, INC | U Tender | 2018-05-01 | 2018-05-09 | 2,576,939 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | U Tender | 2018-05-01 | 2018-05-09 | 858,978 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion deriv | 2018-04-23 | 2018-04-23 | 6,995,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion | 2018-04-23 | 2018-04-23 | 3,179,544 | — | $0 | 3,179,544 | SEC↗ |
| SURF Surface Oncology, Inc. | P Buy | 2018-04-23 | 2018-04-23 | 133,333 | $15.00 | $2.00M | 3,312,877 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-10 | 2018-04-10 | 203,200 | $2.46 | $499.9K | 17,283,670 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-09 | 2018-04-10 | 32,100 | $2.43 | $78.0K | 17,080,470 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-06 | 2018-04-10 | 685,676 | $2.24 | $1.54M | 17,048,370 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-27 | 2018-03-28 | 6,000,000 | $1.92 | $11.52M | 79,978,672 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-26 | 2018-03-28 | 571,164 | $1.90 | $1.09M | 73,978,672 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-23 | 2018-03-23 | 294,090 | $1.95 | $573.5K | 73,407,508 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-22 | 2018-03-23 | 869,574 | $1.90 | $1.65M | 73,113,418 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-21 | 2018-03-23 | 104,844 | $1.81 | $189.8K | 72,243,844 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 10,882,574 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-06 | 2018-03-06 | 12,634 | $59.82 | $755.8K | 9,681,129 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-06 | 2018-03-06 | 3,159 | $59.82 | $189.0K | 739,516 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 4,311 | $59.76 | $257.6K | 736,357 | SEC↗ |